MCID: MSN004
MIFTS: 41

Mesenchymal Cell Neoplasm

Categories: Bone diseases, Cancer diseases

Aliases & Classifications for Mesenchymal Cell Neoplasm

MalaCards integrated aliases for Mesenchymal Cell Neoplasm:

Name: Mesenchymal Cell Neoplasm 12 15 71
Benign Miscellaneous Mesenchymal Tumor 12
Mesenchymal Tumors 15
Mesenchymal Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3350
NCIt 49 C6587 C7059
UMLS 71 C1332517 C1334699

Summaries for Mesenchymal Cell Neoplasm

Disease Ontology : 12 A cell type cancer that has material basis in abnormally proliferating cells derives from embryonic connective tissue that is capable of developing into connective tissue, such as bone, and cartilage, the lymphatic system, and the circulatory system.

MalaCards based summary : Mesenchymal Cell Neoplasm, also known as benign miscellaneous mesenchymal tumor, is related to malignant mesenchymoma and gastrointestinal stromal tumor. An important gene associated with Mesenchymal Cell Neoplasm is KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase), and among its related pathways/superpathways are Glioma and G-protein signaling RAC1 in cellular process. The drugs Carboplatin and Epirubicin have been mentioned in the context of this disorder. Affiliated tissues include bone, breast and liver.

Related Diseases for Mesenchymal Cell Neoplasm

Diseases related to Mesenchymal Cell Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 494)
# Related Disease Score Top Affiliating Genes
1 malignant mesenchymoma 33.5 SSX2 SERPINA3 CD34 CALD1
2 gastrointestinal stromal tumor 32.9 PDGFRA MIR518A1 KIT CD34 ANO1
3 leiomyoma 31.5 PDGFRA KIT HMGA2 CD34
4 leiomyosarcoma 31.3 SERPINA3 PDGFRA MLANA KIT HMGA2
5 pleomorphic lipoma 31.2 SERPINA3 HMGA2 CD34
6 inflammatory myofibroblastic tumor 31.2 TPM4 TPM3 RANBP2 NPM1 KIT FGF19
7 fibroma 31.2 SERPINA3 CD68 CD34
8 rare tumor 31.1 KIT EWSR1
9 neurilemmoma 31.1 SERPINA3 PDGFRA KIT CD34 ANO1
10 undifferentiated pleomorphic sarcoma 31.1 PDGFRA MLANA KIT
11 fibrosarcoma 31.0 SSX2 PDGFRA KIT EWSR1 ALK
12 rhabdomyosarcoma 31.0 SSX2 PDGFRA KIT EWSR1 ALK
13 endometrial stromal sarcoma 31.0 PDGFRA KIT EWSR1 CALD1
14 clear cell sarcoma 31.0 MLANA KIT EWSR1
15 fibrous histiocytoma 31.0 SERPINA3 EWSR1 CD68 CD34 ALK
16 neurofibroma 31.0 PDGFRA MLANA KIT CD34
17 liposarcoma 30.9 PDGFRA HMGA2 EWSR1 CD68 CD34
18 embryonal sarcoma 30.9 SERPINA3 KIT
19 angiosarcoma 30.9 MLANA KIT CD68 CD34
20 histiocytoma 30.8 SERPINA3 KIT EWSR1 CD68 CD34 ALK
21 dermatofibrosarcoma protuberans 30.8 SERPINA3 PDGFRA KIT HMGA2 CD34
22 well-differentiated liposarcoma 30.8 HMGA2 EWSR1 CD34
23 congenital fibrosarcoma 30.8 TPM3 SERPINA3 EWSR1 ALK
24 lipomatosis, multiple 30.8 SERPINA3 MLANA KIT HMGA2 EWSR1 CD34
25 malignant fibroxanthoma 30.8 SERPINA3 HMGA2 CD68 CD34 ALK
26 desmoid tumor 30.7 PDGFRA KIT CD34
27 spindle cell sarcoma 30.7 SSX2 SERPINA3 CD34
28 pleomorphic liposarcoma 30.7 PDGFRA KIT EWSR1
29 hemangiopericytoma, malignant 30.7 SSX2 SERPINA3 KIT FGF23 CD34 CALD1
30 myxoid liposarcoma 30.6 SSX2 HMGA2 EWSR1
31 sarcoma, synovial 30.6 SSX2 SERPINA3 KIT HMGA2 EWSR1 CD34
32 smooth muscle tumor 30.6 SERPINA3 KIT HMGA2 CD34 CALD1
33 extraosseous chondrosarcoma 30.6 SSX2 EWSR1 CD34
34 myofibroma 30.6 SERPINA3 CD34 CALD1
35 reticulosarcoma 30.5 SERPINA3 NPM1 CD68 ALK
36 perivascular epithelioid cell tumor 30.5 MLANA KIT CALD1
37 breast fibroadenoma 30.5 SERPINA3 HMGA2 CD34
38 angiolipoma 30.5 MLANA CD34
39 rhabdomyosarcoma 2 30.5 SSX2 EWSR1 ALK
40 cellular myxoid liposarcoma 30.5 SSX2 KIT EWSR1
41 cutaneous fibrous histiocytoma 30.5 SERPINA3 MLANA CD68 CD34
42 chondroma 30.4 PDGFRA KIT HMGA2 ANO1
43 nasal cavity neoplasm 30.4 EWSR1 CD34
44 plexiform neurofibroma 30.4 PDGFRA KIT CD34
45 meningioma, familial 30.4 SERPINA3 MLANA KIT CD68 CD34
46 connective tissue benign neoplasm 30.4 SERPINA3 KIT CD68 CD34 CALD1
47 perineurioma 30.4 PDGFRA KIT ALK
48 intussusception 30.4 KIT CD34 ANO1
49 chondrosarcoma, extraskeletal myxoid 30.4 SSX2 KIT EWSR1 CD34 CALD1
50 amelanotic melanoma 30.3 SERPINA3 MLANA KIT

Graphical network of the top 20 diseases related to Mesenchymal Cell Neoplasm:



Diseases related to Mesenchymal Cell Neoplasm

Symptoms & Phenotypes for Mesenchymal Cell Neoplasm

Drugs & Therapeutics for Mesenchymal Cell Neoplasm

Drugs for Mesenchymal Cell Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 62)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
2
Epirubicin Approved Phase 3 56420-45-2 41867
3
Dactinomycin Approved, Investigational Phase 3 50-76-0 2019 457193
4
Ifosfamide Approved Phase 3 3778-73-2 3690
5
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
6
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
7
Etoposide Approved Phase 3 33419-42-0 36462
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
9 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
10 Anti-Bacterial Agents Phase 3
11 Antibiotics, Antitubercular Phase 3
12 Topoisomerase Inhibitors Phase 3
13 Anesthetics Phase 3
14 Immunologic Factors Phase 3
15 Anti-Infective Agents Phase 3
16 Immunosuppressive Agents Phase 3
17 Alkylating Agents Phase 3
18
Isophosphamide mustard Phase 3 0
19 Antirheumatic Agents Phase 3
20 Etoposide phosphate Phase 3
21 Antimitotic Agents Phase 3
22 Narcotics Phase 3
23 Liver Extracts Phase 3
24 Anesthetics, General Phase 3
25 Analgesics, Opioid Phase 3
26 Adjuvants, Anesthesia Phase 3
27 Central Nervous System Depressants Phase 3
28 Anesthetics, Intravenous Phase 3
29 Cola Phase 3
30 Analgesics Phase 3
31
Ponatinib Approved, Investigational Phase 2 943319-70-8 24826799
32
Lenograstim Approved, Investigational Phase 2 135968-09-1
33
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
34
Sirolimus Approved, Investigational Phase 2 53123-88-9 5284616 6436030 46835353
35
Bevacizumab Approved, Investigational Phase 2 216974-75-3
36
Everolimus Approved Phase 2 159351-69-6 6442177 70789204
37
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
38
Azacitidine Approved, Investigational Phase 2 320-67-2 9444
39
Vorinostat Approved, Investigational Phase 2 149647-78-9 5311
40
Tyrosine Approved, Investigational, Nutraceutical Phase 2 60-18-4 6057
41 Guadecitabine Investigational Phase 2 929901-49-5
42 Protein Kinase Inhibitors Phase 2
43 Imatinib Mesylate Phase 2 220127-57-1 123596
44
Liposomal doxorubicin Phase 2 31703
45 Antibodies, Monoclonal Phase 2
46 Angiogenesis Inhibitors Phase 2
47 Endothelial Growth Factors Phase 2
48 Antineoplastic Agents, Immunological Phase 2
49 Mitogens Phase 2
50 Antifungal Agents Phase 2

Interventional clinical trials:

(show all 29)
# Name Status NCT ID Phase Drugs
1 MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
2 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
3 Phase II Study Evaluating PegLiposomal Doxorubicin (PLD) and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Completed NCT00815945 Phase 2 PegLiposomal Doxorubicin;Carboplatin
4 High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum Completed NCT00592345 Phase 1, Phase 2
5 Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor Following Failure of Prior Tyrosine Kinase Inhibitor Therapy Completed NCT01874665 Phase 2 Ponatinib
6 MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
7 A Multi-center, Single Arm, Phase II Study of Adjuvant Imatinib (Glivec®) in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor ( GIST) Completed NCT01172548 Phase 2 imatinib mesylate
8 Women's Triple-Negative First-Line Study: A Phase II Trial of Liposomal Doxorubicin, Bevacizumab and Everolimus (DAE) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy Recruiting NCT02456857 Phase 2 Everolimus;Pegylated Liposomal Doxorubicin Hydrochloride
9 68Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia Recruiting NCT03736564 Phase 1, Phase 2
10 A Phase II Trial of the DNA Methyl Transferase Inhibitor, SGI-110 (Guadecitabine), In Children And Adults With Wild Type GIST, Pheochromocytoma And Paraganglioma Associated With Succinate Dehydrogenase Deficiency And HLRCC-Associated Kidney Cancer Recruiting NCT03165721 Phase 2 SGI-110 (guadecitabine)
11 Phase II Trial of Vandetanib (ZD6474, Caprelsa(R) in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors Active, not recruiting NCT02015065 Phase 2 Vandetanib
12 A Pilot Study of Peroral Vorinostat (SAHA) in Patients With Refractory Histone Deacetylase-positive Uterine Sarcoma Terminated NCT03509207 Phase 2 Vorinostat Oral Capsule
13 Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore): A Prospective Randomized, Controlled Multicenter Study Withdrawn NCT02766842 Phase 2
14 Phase I Study of Donor Derived,Gene Modified, Multi-virus-specific, Cytotoxic T-Lymphocytes Redirected to GD2 for Relapsed/Refractory Neuroblastoma Post-allo Stem Cell Transplantation With Submyeloblative Conditioning Completed NCT01460901 Phase 1
15 First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors Recruiting NCT01417546 Phase 1 NHS-IL-12
16 68Ga-DOTATATE PET/CT for Detection and Evaluation of the Causative Tumor of Oncogenic Osteomalacia Unknown status NCT01524016 Early Phase 1 68Ga-DOTATATE
17 Role of Doppler Ultrasound in Evaluation of Superficial Soft Tissue Masses Unknown status NCT03171857
18 Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia Unknown status NCT01660308
19 The Clinical Relevance of Immune Cells and Circulating Tumor Cells in Patients With Head and Neck Cancer Unknown status NCT02420600
20 Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors Completed NCT00099762
21 Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors Completed NCT02884154
22 Accuracy and Feasibility of a Morpho-anatomical Classification Oriented Laparoscopic Resection of Gastric Stromal Tumors in Advanced Laparoscopic Surgery Center: a Prospective Cohort Study Completed NCT02662478
23 Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia Recruiting NCT04045834
24 Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (GIST) in a Real-life Setting: the METAGIST Observational Study Recruiting NCT03963544 oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations
25 The "BCB-sarcomes" Database: the Database of the French Sarcoma Group Dedicated to the Collection of Clinical and Biological Data for All Sarcomas Recruiting NCT03978039 Chemotherapy;Immunotherapeutic Agent;target treatment
26 the Prospective, Randomized and Comparative Clinical Study of Laparoscopic and Endoscopic Cooperative Surgery in the Treatment of Gastrointestinal Stromal Tumor Recruiting NCT02763748
27 GISAR German Interdisciplinary Sarcoma Registry Recruiting NCT04122872
28 A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules Recruiting NCT04143048
29 Application of Laparoscopy Combined With Endoscopy Surgery in the Treatment of Gastric Stromal Tumors Recruiting NCT03601234

Search NIH Clinical Center for Mesenchymal Cell Neoplasm

Genetic Tests for Mesenchymal Cell Neoplasm

Anatomical Context for Mesenchymal Cell Neoplasm

MalaCards organs/tissues related to Mesenchymal Cell Neoplasm:

40
Bone, Breast, Liver, Lung, Uterus, Kidney, Skin

Publications for Mesenchymal Cell Neoplasm

Articles related to Mesenchymal Cell Neoplasm:

(show top 50) (show all 2555)
# Title Authors PMID Year
1
A novel EWSR1-VGLL1 gene fusion in a soft tissue malignant myoepithelial tumor. 61
31697442 2020
2
Uncommon Prostate Malignant Neoplasms. 61
32015293 2020
3
Bone Sarcomas and Desmoids. 61
31739943 2020
4
Lipomatous Tumors in Pediatric Patients: A Retrospective Analysis of 50 cases. 61
31282548 2020
5
First case report of tongue squamous cell carcinoma in a neurofibromatosis type 1 patient and review of pathogenesis of carcinoma in neurofibromatosis type 1. 61
32031137 2020
6
ALK expressed in a gastrointestinal stromal tumor harboring PDGFRA p. D842V mutation:a case report. 61
32005261 2020
7
Gastric schwannoma: a diagnosis that should be known in 2019. 61
31976062 2020
8
Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors. 61
31931874 2020
9
Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review. 61
32020209 2020
10
[Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review]. 61
30937490 2020
11
Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines. 61
31746397 2020
12
ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change. 61
31938824 2020
13
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature. 61
32009477 2020
14
Rare mesenchymal antral gastric tumors: Case reports of glomus tumor and plexiform fibromyxoma. 61
31737150 2020
15
Gastric schwannoma: A rarity among mesenchymal tumors of the gastrointestinal tract. 61
31427112 2020
16
Mesenchymal Tumors with RREB1-MRTFB Fusion Involving the Mediastinum: Extra-Glossal Ectomesenchymal Chondromyxoid Tumors? 61
31991003 2020
17
Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin. 61
31139992 2020
18
What is new in pericytomatous, myoid, and myofibroblastic tumors? 61
31705190 2020
19
Recurrent RET Gene Fusions in Pediatric Spindle Mesenchymal Neoplasms. 61
31994201 2020
20
Keloid scarring or disease: Unresolved quasi-neoplastic tendencies in the human skin. 61
31943508 2020
21
Collective cancer invasion forms an integrin-dependent radioresistant niche. 61
31658985 2020
22
Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis. 61
31934916 2020
23
Pediatric gastrointestinal stromal tumor: Report of two novel patients harboring germline variants in SDHB and SDHC genes. 61
31883676 2019
24
Malignant peripheral nerve sheath tumor of the bladder A case report. 61
31965114 2019
25
[Familial adenomatous polyposis, desmoid tumors and Gardner syndrome]. 61
31882269 2019
26
Para-anal lipoma as a rare consequence to perineal trauma. Case-report and review of the literature. 61
29734868 2019
27
[Hypophosphatemic osteomalacia caused by urinary mesenchymal tumor: A case report]. 61
31848524 2019
28
Calcification and ossification in conventional schwannoma: A clinicopathologic study of 32 cases. 61
31793063 2019
29
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone. 61
31873172 2019
30
Clinico-pathological features of gynecological myopericytoma: a challenging diagnosis in an exceptional location. 61
31410559 2019
31
Intramastoid Phosphaturic Mesenchymal Tumor Causing Hypophosphatemic Osteomalacia Detected on 68Ga-DOTATATE PET/CT But Not on 99mTc-Sestamibi and 18F-FDG Scans. 61
31867080 2019
32
Phosphaturic mesenchymal tumor: Case report. 61
31681451 2019
33
Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion. 61
31305268 2019
34
[Pathological and molecular features of malignancies underlined by BAF complexes inactivation]. 61
31255411 2019
35
Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications. 61
31792355 2019
36
Evaluation of cytology and histopathology for the diagnosis of canine orbital neoplasia: 112 cases (2004-2019) and review of the literature. 61
31693288 2019
37
Oral masses in African pygmy hedgehogs. 61
31585523 2019
38
Endoscopic ultrasound-guided fine-needle aspiration biopsy of gastric schwannoma: Cytomorphologic features and diagnostic pitfalls. 61
31343112 2019
39
Primary pulmonary myxoid sarcoma with an unusual gene fusion between exon 7 of EWSR1 and exon 5 of CREB1. 61
31776646 2019
40
Non-epithelial tumors of the larynx: case series of 12 years. 61
31256243 2019
41
Huge Gastrointestinal Stromal Tumor of the Jejunum Presenting as Bowel Obstruction: A Rare Presentation. 61
31768355 2019
42
Racial Disparity in Incidence and Survival for Gastrointestinal Stromal Tumors (GISTs): an Analysis of SEER Database. 61
31215017 2019
43
MUC4 Expression in Angiomatoid Fibrous Histiocytoma. 61
31652145 2019
44
[Immunotherapy of Gastrointestinal Stromal Tumors]. 61
31699203 2019
45
Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignancies. 61
31933549 2019
46
Prostatic Stromal Tumors of Uncertain Malignant Potential. 61
31254570 2019
47
Utility of YWHAE fluorescent in-situ hybridisation in mesenchymal tumors of uterus- An initial experience from tertiary oncology centre in India. 61
31607703 2019
48
Feasibility of laparoscopic isolated caudate lobe resection for rare hepatic mesenchymal neoplasms. 61
31667169 2019
49
Transvaginal excision of rectal stromal tumors: case reports and a literature review. 61
31587664 2019
50
Short-term outcomes after duodenal surgery for mesenchymal tumors: a retrospective analysis from a single tertiary referral center. 61
31270684 2019

Variations for Mesenchymal Cell Neoplasm

Expression for Mesenchymal Cell Neoplasm

Search GEO for disease gene expression data for Mesenchymal Cell Neoplasm.

Pathways for Mesenchymal Cell Neoplasm

Pathways related to Mesenchymal Cell Neoplasm according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.32 PDGFRA FGF23 FGF19 EML4 ALK
2
Show member pathways
12.06 PDGFRA KIT FGF23 FGF19 ALK
3 11.89 TPM3 PDGFRA KIT FGF23 FGF19 EML4
4 11.73 PDGFRA NPM1 KIT ALK
5 10.91 NPM1 EML4 ALK
6 10.71 PDGFRA KIT FGF23 FGF19 ALK
7 10.69 TPM4 TPM3 CALD1
8 10.58 PDGFRA FGF23

GO Terms for Mesenchymal Cell Neoplasm

Cellular components related to Mesenchymal Cell Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 muscle thin filament tropomyosin GO:0005862 8.62 TPM4 TPM3

Biological processes related to Mesenchymal Cell Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 MAPK cascade GO:0000165 9.26 PDGFRA KIT FGF23 FGF19
2 positive regulation of phospholipase C activity GO:0010863 9.16 PDGFRA KIT
3 positive regulation of protein kinase B signaling GO:0051897 8.92 PDGFRA KIT FGF23 FGF19

Molecular functions related to Mesenchymal Cell Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.89 TPM4 TPM3 SSX2 SERPINA3 RANBP2 PDGFRA
2 transmembrane receptor protein tyrosine kinase activity GO:0004714 8.8 PDGFRA KIT ALK

Sources for Mesenchymal Cell Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....